# Celtaxsys, Inc.: Form D filings

Celtaxsys, Inc., a biotechnology company in Atlanta, GA, filed 3 Form D notices with the SEC between 2009 and 2015. The latest, on June 17, 2015, reports $21.6 million sold of a $40 million offering to 8 investors.

Find out what Celtaxsys, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Celtaxsys%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Celtaxsys%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fceltaxsys-inc-1334381)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Celtaxsys%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Celtaxsys%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fceltaxsys-inc-1334381)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 201 17th Street, Suite 530, Atlanta, GA, 30363
- Phone: (470) 206-0153
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1334381

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 17, 2015 | New notice | $40,003,981 | $21,628,985 | $18,374,996 | 8 | Jun 3, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1334381/000133438115000002/0001334381-15-000002-index.htm) |
| Oct 29, 2010 | New notice | $10,653,500 | $4,231,386 | $6,422,114 | 6 | Oct 25, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1334381/000133438110000001/0001334381-10-000001-index.htm) |
| May 7, 2009 | New notice | $5,000,000 | $2,040,000 | $2,960,000 | 5 | May 7, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1334381/000133438109000004/0001334381-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| H. Daniel Perez, M.D. | Director |  |
| Maxim Daniel Gorbachev | Director |  |
| Nicole P. Vitullo | Director |  |
| Eric Daniel Springman | Executive Officer |  |
| Sanjeev P. Ahuja, M.D. | Executive Officer |  |
| Gerry Daniel Brunk | Director |  |
| Greg Duncan | Executive Officer, Director |  |
| William P. Reddick | Executive Officer |  |
| Michael W. Masters | Director |  |

## Other biotechnology companies in Georgia that filed recently

- [Opus Medical Therapies, LLC](https://specstream.ai/data/form-d/company/opus-medical-therapies-llc-1785788) $485,089 · Sep 22, 2026
- [Airway Therapeutics, Inc.](https://specstream.ai/data/form-d/company/airway-therapeutics-inc-1733867) $43.5 million · Sep 9, 2026
- [FEMASYS INC](https://specstream.ai/data/form-d/company/femasys-inc-1339005) $30 million · Aug 20, 2026

[Every Form D from the week of Jun 15, 2015](https://specstream.ai/data/form-d/week/2015-06-15) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Celtaxsys, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).